Summary
HCA Healthcare, Inc. (HCA) filed an 8-K on November 5, 2003, to report on the issuance and sale of $600 million in aggregate principal amount of new debt securities. This issuance includes $350 million of 5.25% Notes due November 6, 2008, and $250 million of 7.50% Notes due November 6, 2033. The filing primarily serves to disclose the exhibits related to this significant debt financing, including the Underwriting Agreement (Terms) and the specific note indentures. This debt issuance represents a material event for investors as it impacts the company's capital structure and financial leverage. The long-term nature of these notes, particularly the 2033 maturity, indicates a strategy to secure long-term funding. Investors should note the specific coupon rates and maturity dates, which provide insight into the cost of capital and the company's future debt obligations.
Key Highlights
- 1HCA Healthcare issued $350 million in 5.25% Notes due November 6, 2008.
- 2HCA Healthcare issued $250 million in 7.50% Notes due November 6, 2033.
- 3Total aggregate principal amount of new debt issued is $600 million.
- 4The filing includes the Underwriting Agreement (Terms) dated October 31, 2003.
- 5The specific indentures for the 5.25% Notes due 2008 and 7.50% Notes due 2033 are filed as exhibits.
- 6This event signifies a substantial financing activity for HCA, impacting its capital structure.